Lansinoh Laboratories, Inc. has donated $20,000 to help fund the new InfantRisk
Center at Texas
Tech University in Amarillo, Texas, scheduled to open in the summer
of 2010. This new Center will provide pregnant and breastfeeding women
and their healthcare providers with accurate information and
evidence-based counsel on medications that are safe to use and
alternatives to drug-based treatments.
The InfantRisk Center, also supported by the Laura
W. Bush Institute for Women’s Health at the University, is the
brainchild of Dr.
Thomas W. Hale, Professor of Pediatrics and Assistant Dean of
Research at Texas Tech University School of Medicine. Dr. Hale is
regarded as the foremost expert in the effect of medications on human
lactation. The Center will also be staffed by faculty from the Texas
Tech University School of Medicine departments of Pediatrics and
Obstetrics and Gynecology, and the School of Pharmacy. This new center
will be available to receive calls between 8 a.m. and 5 p.m. CST from
Monday to Friday from moms across the country. Consultants will answer
questions about specific prescription and over-the-counter medications.
Not only will the InfantRisk Center be a lifesaving resource for moms,
it will be a means to gather reliable, trusted, and evidence-based
information that will be accessible for dissemination by healthcare
providers throughout the U.S. Moms will also have the opportunity to
share personal experiences, medical histories, and register in pregnancy
and lactation registries, so that their information can be
systematically studied and analyzed. This new information will help
drive further research on the effects of medications on pregnancies,
breastfed infants, and their mothers, and ultimately, will enhance
babies’ health.
“It’s great that a resource like this will finally be available in the
U.S.,” says Gina Ciagne, CLC and Director of Breastfeeding and Consumer
Relations at Lansinoh. “The InfantRisk Center is going to be an
excellent resource to help clear up any confusion and misinformation
regarding medications and whether or not they are safe to use during
pregnancy and lactation. Very often, moms are urged to stop
breastfeeding because of a perceived conflict with a medication but that
is not always necessary. If the incidence of premature weaning from
breastfeeding can be reduced because of information and support that the
Center will provide, that will be a great victory.”
Dr. Thomas Hale says, “This new center will ultimately provide millions
and millions of mothers with answers to their medication questions while
they are pregnant or breastfeeding. We actually know most of these
answers, but this new center will help distribute this information to
the mothers of the world.”
Donations
to the InfantRisk Center can be submitted online.
For more information about the initiative, listen
to an interview with Dr. Thomas Hale on Lansinoh’s blog, ByMomsForMoms.
ABOUT LANSINOH LABORATORIES, INC.
Founded in 1984 by a breastfeeding mother, Lansinoh
Laboratories, Inc., Alexandria, Va., is a global leader of premium
products by and for breastfeeding mothers. The company’s expanding
product line is available in over 25,000 retail stores nationwide.
Press contact:
Gregory
FCA
Robyn Ungar
Associate Vice President
610-228-2131
Robyn@GregoryFCA.com
or
Company
contact:
Lansinoh Laboratories, Inc.
Jennifer Moyer
Vice
President of Marketing
703-299-6460
JMoyer@Lansinoh.com